Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA 4.45EWJ 2.89TECK.B.TO 5.26CNQ.TO -0.07HHL.TO 0.035SYLD 1.15HAC.TO 0.14TRU -2.15
Pfizer Inc (PFE)

NYSE:PFE

Pfizer Inc (PFE)

26.16
+0.56 (2.19%)
as of Jun 11, 2026, 8:30:47 pm Market Open.
322 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
TOP PICK

Pfizer Inc(PFE)

Jan 07, 2002
Likes the pharmaceutical sector. Has a good pipeline for its drugs.
Photo of Neil MurdockNeil MurdockUnlock Rating
$39.70

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jan 04, 2002
Likes the sector. Well positioned. Prefers over Merc.
Photo of John ZechnerJohn ZechnerUnlock Rating
$39.40

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

Jan 03, 2002
(Was a top pick on Sept 26 up 3.5%) Will have to buy some biotechs to keep their pipelines growing.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$39.70

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

Jan 02, 2002
(Was a top pick on Sept 10 up 4.4%) Not the best time to buy pharmaceuticals. Buy under $40.
Photo of Brad WillockBrad WillockUnlock Rating
$39.90

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Dec 28, 2001
Very expensive. US drug companies are having problems.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$40.40

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Pfizer Inc(PFE)

Dec 19, 2001
Good cash flow. Will grow 20% + 2002/03 and 15% 2004. A good price.
Photo of Michelle CalpinMichelle CalpinUnlock Rating
$41.10

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Dec 17, 2001
Excellent company. Good dividends.
Photo of Bob StodgellBob StodgellUnlock Rating
$40.33

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Dec 12, 2001
Great company, but economy is hitting all drug companies. Too high now.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$40.24

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

Nov 28, 2001
(Was a top pick on Sept 26 up 16%) Still likes. A lot more upside yet.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$43.17

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Nov 28, 2001
Has a good pipeline for new drugs.
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$43.17

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY ON WEAKNESS

Pfizer Inc(PFE)

Nov 08, 2001
Good products. Buy on weakness.
Photo of Brendan CaldwellBrendan CaldwellUnlock Rating
$42.30

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Oct 30, 2001
One of the best drug companies.
Photo of Neil MurdockNeil MurdockUnlock Rating
$42.45

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Pfizer Inc(PFE)

Oct 30, 2001
(Was a top pick on April 12 up 4.6%) Good sector.
Photo of Neil MurdockNeil MurdockUnlock Rating
$42.45

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Oct 25, 2001
Trades in a range. Good company.
Photo of Brendan CaldwellBrendan CaldwellUnlock Rating
$43.01

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Sep 27, 2001
Stable. Trading in the mid $20's is an earning multiple based on the 15% growth expected. Has competition.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$39.75

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
Showing 751 to 765 of 801 entries
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV -2.21$161.55
WSP.TO 0.31$183.77
VRTX 9.33$445.04
OTEX.TO 0.24$30.52
CCO.TO 5.6$138.04

Today's Top Picks

NVDA 4.45$204.87
EWJ 2.89$92.18
TECK.B.T… 5.26$88.81
CNQ.TO -0.07$63.52
HHL.TO 0.035$6.945

Popular Articles

Latest Sell Signals

TD.TO 2.57$162.22
MBLY 0.42$9.56
ASAN -0.12$7.46
MODG 0.53$16.79
NVTS 1.71$22.21

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica